Finally, there was an equivalent increase in regulatory T cells (Tregs, CD4+FOXP3+) among mutant genotypes in the end-stage lymphomas (Supplementary Fig. 2n, o), suggesting additional layers of immune dysfunction. The gene discussed is CD4; the disease is lymphoma.